186 related articles for article (PubMed ID: 24992338)
1. Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.
Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Ouattara A; Takala-Harrison S; Berry AA; Doumbo OK; Plowe CV
PLoS One; 2014; 9(7):e101783. PubMed ID: 24992338
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein.
Gandhi K; Thera MA; Coulibaly D; Traoré K; Guindo AB; Doumbo OK; Takala-Harrison S; Plowe CV
Am J Trop Med Hyg; 2012 May; 86(5):775-81. PubMed ID: 22556073
[TBL] [Abstract][Full Text] [Related]
4. Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran.
Zakeri S; Avazalipoor M; Mehrizi AA; Djadid ND; Snounou G
Am J Trop Med Hyg; 2007 Jun; 76(6):1046-51. PubMed ID: 17556609
[TBL] [Abstract][Full Text] [Related]
5. T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution?
Jalloh A; Jalloh M; Matsuoka H
Malar J; 2009 Jun; 8():120. PubMed ID: 19500348
[TBL] [Abstract][Full Text] [Related]
6. Effect of malaria transmission reduction by insecticide-treated bed nets (ITNs) on the genetic diversity of Plasmodium falciparum merozoite surface protein (MSP-1) and circumsporozoite (CSP) in western Kenya.
Kariuki SK; Njunge J; Muia A; Muluvi G; Gatei W; Ter Kuile F; Terlouw DJ; Hawley WA; Phillips-Howard PA; Nahlen BL; Lindblade KA; Hamel MJ; Slutsker L; Shi YP
Malar J; 2013 Aug; 12():295. PubMed ID: 23978002
[TBL] [Abstract][Full Text] [Related]
7. Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Waitumbi JN; Anyona SB; Hunja CW; Kifude CM; Polhemus ME; Walsh DS; Ockenhouse CF; Heppner DG; Leach A; Lievens M; Ballou WR; Cohen JD; Sutherland CJ
PLoS One; 2009 Nov; 4(11):e7849. PubMed ID: 19924281
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda.
Agwang C; Erume J; Okech B; Olobo J; Egwang TG
Malar J; 2020 Oct; 19(1):361. PubMed ID: 33032613
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.
Takala SL; Coulibaly D; Thera MA; Dicko A; Smith DL; Guindo AB; Kone AK; Traore K; Ouattara A; Djimde AA; Sehdev PS; Lyke KE; Diallo DA; Doumbo OK; Plowe CV
PLoS Med; 2007 Mar; 4(3):e93. PubMed ID: 17355170
[TBL] [Abstract][Full Text] [Related]
10. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
[TBL] [Abstract][Full Text] [Related]
11. Genetic Diversity and Natural Selection of the Plasmodium knowlesi Circumsporozoite Protein Nonrepeat Regions.
Fong MY; Ahmed MA; Wong SS; Lau YL; Sitam F
PLoS One; 2015; 10(9):e0137734. PubMed ID: 26379157
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.
Alloueche A; Milligan P; Conway DJ; Pinder M; Bojang K; Doherty T; Tornieporth N; Cohen J; Greenwood BM
Am J Trop Med Hyg; 2003 Jan; 68(1):97-101. PubMed ID: 12556156
[TBL] [Abstract][Full Text] [Related]
13. Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate.
Mohamed NS; AbdElbagi H; Elsadig AR; Ahmed AE; Mohammed YO; Elssir LT; Elnour MB; Ali Y; Ali MS; Altahir O; Abubakr M; Siddig EE; Ahmed A; Omer RA
Malar J; 2021 Nov; 20(1):436. PubMed ID: 34758827
[TBL] [Abstract][Full Text] [Related]
14. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
[TBL] [Abstract][Full Text] [Related]
15. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse
Noe AR; Terry FE; Schanen BC; Sassano E; Hindocha P; Phares TW; Moise L; Christen JM; Tucker KD; Kotraiah V; Drake DR; Martin WD; De Groot AS; Gutierrez GM
Front Immunol; 2021; 12():689920. PubMed ID: 34168657
[TBL] [Abstract][Full Text] [Related]
16. Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi.
Bailey JA; Mvalo T; Aragam N; Weiser M; Congdon S; Kamwendo D; Martinson F; Hoffman I; Meshnick SR; Juliano JJ
J Infect Dis; 2012 Aug; 206(4):580-7. PubMed ID: 22551816
[TBL] [Abstract][Full Text] [Related]
17. A survey of the Th2R and Th3R allelic variants in the circumsporozoite protein gene of P. falciparum parasites from western Thailand.
Kumkhaek C; Phra-ek K; Singhasivanon P; Looareesuwan S; Hirunpetcharat C; Brockman A; Grüner AC; Lebrun N; Rénia L; Nosten F; Snounou G; Khusmith S
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):281-7. PubMed ID: 15691125
[TBL] [Abstract][Full Text] [Related]
18. Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria-endemic regions of Papua New Guinea and Brazil.
Shi YP; Alpers MP; Povoa MM; Lal AA
Am J Trop Med Hyg; 1992 Dec; 47(6):844-51. PubMed ID: 1281968
[TBL] [Abstract][Full Text] [Related]
19. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
[TBL] [Abstract][Full Text] [Related]
20. Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi.
Khan S; Parrillo M; Gutierrez AH; Terry FE; Moise L; Martin WD; De Groot AS
Hum Vaccin Immunother; 2020; 16(2):214-227. PubMed ID: 30614773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
